Nifedipine Tablet, Extended Release
Product Images NDC 71335-2132

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 71335-2132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01 (Image 01)

Chemical structure of nifedipine showing its molecular arrangement including nitro, methoxycarbonyl, and acetyl groups on a dihydropyridine ring system.*

FDA Label Image

02 (Image 02)

A data table comparing the percentage incidence of adverse effects in patients taking Nifedipine extended-release tablets versus placebo. The adverse effects listed include headache, fatigue, dizziness, constipation, and nausea with corresponding percentages for each group.*

FDA Label Image

03 (Image 03)

A data table comparing the percentage of various adverse effects reported in subjects taking Nifedipine capsules versus placebo. The table lists adverse effects such as dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion, with corresponding percentages for each group.*

FDA Label Image

Label (Lbl713352132)

Nifedipine ER 90 mg extended-release tablet label from Bryant Ranch Prepack. The label notes packaging by Bryant Ranch Prepack in Burbank, CA, and displays NDC 71335-2132. It includes storage instructions to keep at 20°-25°C (68°-77°F) and a caution to keep drugs out of reach of children. References comparison to Procardia ER 90mg tablet by Novast Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.